Last updated: 4 months ago
Compugen Ltd. Report: January 2025 Form 6-K on Phase 1 Clinical Trial Announcement
Compugen Ltd. filed a Form 6-K on January 8, 2025, detailing the first patient dosed in a Phase 1 trial for COM503. This pivotal update could impact investor confidence and market position.